Fatty liver disease and primary liver cancer: disease mechanisms, emerging therapies and the role of bariatric surgery

Luke V Selby; Aslam Ejaz; Stacy A Brethauer; Timothy M Pawlik

doi:10.1080/13543784.2020.1721457

Fatty liver disease and primary liver cancer: disease mechanisms, emerging therapies and the role of bariatric surgery

Expert Opin Investig Drugs. 2020 Feb;29(2):107-110. doi: 10.1080/13543784.2020.1721457. Epub 2020 Jan 27.

Authors

Luke V Selby¹, Aslam Ejaz¹, Stacy A Brethauer¹, Timothy M Pawlik¹

Affiliation

¹ Department of Surgery, Divisions of Surgical Oncology and GI/General Surgery, The Ohio State University Medical Center, Columbus, OH, USA.

PMID: 31986920
DOI: 10.1080/13543784.2020.1721457

No abstract available

Keywords: NASH; bariatric surgery; hepatocellular carcinoma; lifestyle intervention; metabolic syndrome; nafld; nonalcoholic steatohepatitis; obesity; obeticholic acid; primary liver cancer.

Publication types

Editorial

MeSH terms

Bariatric Surgery / methods*
Disease Progression
Humans
Liver Neoplasms / pathology
Liver Neoplasms / therapy*
Non-alcoholic Fatty Liver Disease / physiopathology
Non-alcoholic Fatty Liver Disease / therapy*